Serum folate and low-density lipoprotein particle size

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 12, 2010, Pages 1218-1225

  Kim, Dal Sik ^a   Kim, Young Kon ^b   Park, Hyeong Kyu ^c   Cho, Young I ^d   Jeong, Seul Ki ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Soonchunhyang University   (South Korea)

^d DREXEL UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Folate; Ldl particle size; Tg hdl cholesterol ratio

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; FATTY LIVER; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PARTICLE SIZE; VITAMIN BLOOD LEVEL;

EID: 78650835754     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.5629     Document Type: Article

References (34)

1. The world health report 2003 - Shaping the future, In, Geneva, World Health Organization, 2003
2. Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA, 2004; 291: 2616-2622
3. Lorenzo C, Williams K, Hunt KJ, Haffner SM: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care, 2006; 29: 625-630
4. Tolonen H, Keil U, Ferrario M, Evans A, for the WHOMP: Prevalence, awareness and treatment of hyper-cholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol, 2005; 34: 181-192
5. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 2002; 106: 3143-3421
6. Kim DS, Kim YK, Chae HJ, Park TS, Cho YI, Jeong SK: Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome. Diabetol Metab Syndr, 2010; 2: 18
7. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B: The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol, 2000; 20: 2140-2147
8. Rizzo M, Pernice V, Frasheri A, Berneis K: Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis, 2008; 197: 237-241
9. Mykkanen L, Kuusisto J, Haffner SM, Laakso M, Austin MA: LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol, 1999; 19: 2742-2748
10. Sirtori CR, Calabresi L, Pisciotta L, Cattin L, Pauciullo P, Montagnani M, Manzato E, Bittolo Bon G, Fellin R: Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. Nutr Metab Cardiovasc Dis, 2005; 15: 47-55
11. Rizzo M, Berneis K: Low-density lipoprotein size and cardiovascular risk assessment. QJM, 2006; 99: 1-14
12. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F: Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis, 2009; 19: 401-408
13. Ntyintyane LM, Panz VR, Raal FJ, Gill GV: Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease. QJM, 2008; 101: 111-119
14. Austin M, Krauss R: Genetic control of low-density-lipo-protein subclasses. Lancet, 1986; 328: 592-595
15. Jeong SK, Kim YK, Park JW, Shin YJ, Kim DS: Impact of visceral fat on the metabolic syndrome and nonalcoholic fatty liver disease. J Korean Med Sci, 2008; 23: 789-795
16. Lee CW, Lee SH, Lee MS, Suh SK, Yoon NK, Ahn EJ: Measurement properties of Baecke's habitual physical activity questionnaire and related variables. J Korean Pub Health Asso, 1992; 18: 38-53
17. Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 2002; 123: 1705-1725
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112: 2735-2752
19. Touboul PJ, Hennerici MG, Meairs S, Adams H, Ama-renco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M: Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis, 2007; 23: 75-80
20. Matthews DR, Hosker J P, Rudenski AS, Naylor BA, Treacher D F, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabe-tologia, 1985; 28: 412-419
21. Havel RJ, Rapaport E: Management of primary hyperlip-idemia. N Engl J Med, 1995; 332: 1491-1498
22. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis, 1994; 106: 241-253
23. Kondo A, Muranaka Y, Ohta I, Notsu K, Manabe M, Kotani K, Saito K, Maekawa M, Kanno T: Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem, 2001; 47: 893-900
24. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res, 1993; 34: 1255-1274
25. Ito MK: The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin. Ann Pharmacother, 2004; 38: 277-285
26. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X: Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 2007; 369: 1876-1882
27. Lim MH, Cho YI, Jeong SK: Homocysteine and pulsatil-ity index of cerebral arteries. Stroke, 2009; 40: 3216-3220
28. Jeong SK, Seo JY, Cho YI: Homocysteine and internal carotid artery occlusion in ischemic stroke. J Atheroscler Thromb 2010; 17: 963-969
29. Pote MS, Gandhi NM, Mishra KP: Antiatherogenic and radioprotective role of folic acid in whole body gamma-irradiated mice. Mol Cell Biochem, 2006; 292: 19-25
30. Lekhal S, Borvik T, Nord A, Hansen J-B: Decreased lipo-protein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction. Nutr Metab Cardiovasc Dis, 2008; 18: 700-706
31. Yi-Deng J, Tao S, Hui-Ping Z, Jian-Tuan X, Jun C, Gui-Zhong L, Shu-Ren W: Folate and ApoE DNA Methyla-tion Induced by homocysteine in human monocytes. DNA Cell Biol, 2007; 26: 737-744
32. Heeren J, Beisiegel U, Grewal T: Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol, 2006; 26: 442-448
33. Shin MH, Kim HN, Cui LH, Kweon SS, Park KS, Heo H, Nam HS, Jeong SK, Chung EK, Choi JS: The effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci, 2005; 20: 361-366
34. Rizzo M, Berneis K: Should we measure routinely the LDL peak particle size? Int J Cardiol, 2006; 107: 166-170